Hendrik Nogai

Chief Tech/Sci/R&D Officer at RYVU THERAPEUTICS S.A.

Net worth: 88 596 $ as of 31/07/2026

Consumer Services

Health Technology

Profile

Dr. Hendrik Nogai, MD, is a Chief Medical Officer at Ryvu Therapeutics SA. Dr. Nogai was previously employed as a Vice President by Bayer Pharmaceuticals /Switzerland/.
He received his doctorate degree from Ludwig-Maximilians-Universität München, a doctorate degree from Charité - Universitätsmedizin Berlin and a doctorate degree from Harvard Medical School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
RYVU THERAPEUTICS SA 0.1%	30/09/2025	22,500 ( 0.1% )	88 596 $	31/07/2026

Hendrik Nogai active positions

Companies	Position	Start
RYVU THERAPEUTICS S.A.	Chief Tech/Sci/R&D Officer	01/02/2022

All active positions of Hendrik Nogai

Former positions of Hendrik Nogai

Companies	Position	End
Bayer Pharmaceuticals /Switzerland/	Corporate Officer/Principal	01/01/2022

See the detail of Hendrik Nogai's experience

Training of Hendrik Nogai

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hendrik Nogai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Charité - Universitätsmedizin Berlin Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ryvu Therapeutics SA Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology	Health Technology
Bayer Pharmaceuticals /Switzerland/